复方中药圣愈汤治疗股骨头坏死机制的网络药理(6)

写作指南：该研究遵守国际医学期刊编辑委员会《学术研究实验与报告和医学期刊编辑与发表的推荐规范》。

文章查重：文章出版前已经过专业反剽窃文献检测系统进行3 次查重。

文章外审：文章经小同行外审专家双盲外审，同行评议认为文章符合期刊发稿宗旨。

文章版权：文章出版前杂志已与全体作者授权人签署了版权相关协议。

开放获取声明：这是一篇开放获取文章，根据《知识共享许可协议》“署名-非商业性使用-相同方式共享4.0”条款，在合理引用的情况下，允许他人以非商业性目的基于原文内容编辑、调整和扩展，同时允许任何用户阅读、下载、拷贝、传递、打印、检索、超级链接该文献，并为之建立索引，用作软件的输入数据或其它任何合法用途。

4 参考文献 References

[1] 赵德伟,胡永成.成人股骨头坏死诊疗标准专家共识(2012 年版)[J].中华关节外科杂志(电子版),2012,6(3):479-484

[2] ZHAO DW, YU M, HU K, et al. Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the chinese population: results from a nationally representative survey. Chin Med J (Engl).2015;128(21):2843-2850.

[3] 周明旺,陈彦同,李盛华,等.股骨头坏死保髋治疗[J].中国骨质疏松杂志,2019,25(9):1351-1356.

[4] 陈卫衡,何伟,童培建,等.股骨头坏死中医辨证标准(2019 年版)[J].中医正骨,2019,31(6):1-2.

[5] 王晨,施杞.施杞辨治股骨头坏死经验撷菁[J].上海中医药杂志,2015,49(11):1-3.

[6] 刘粉叶,沙其朋,王娓娓.益气养血法对骨髓抑制小鼠骨髓造血的促增殖作用及机制[J].中华中医药学刊,2019,37(10):2328-2331.

[7] HAI YX, YAN QZ, ZHEN ML, et al. ETCM:an encyclopaedia of traditional Chinese medicine. Nucleic Acids Res. 2019;47(D1):D976-D982.

[8] EDGAR R, DOMRACHEV M, LASH AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data Acids Res. 2002;30(1):207-210.

[9] TROTT O, OLSON AJ. AutoDock Vina:improving the speed and accuracy of docking with a new scoring function,efficient optimization, and multithreading[J].J Comput Chem. 2010;31(2):455-461.

[10] 徐森楠,庄莉,翟园园,等.基于网络药理学研究二至丸防治骨质疏松症的物质基础与作用机制[J].中国药学杂志,2018,53(22):1913-1920.

[11] YU X, ZHANG D, CHEN X, et al. Effectiveness of various hip preservation treatments for non-traumatic osteonecrosis of the femoral head: a network meta-analysis of randomized controlled trials. J Orthop Sci.2018;23(2):356-364.

[12] PISANI LP, ESTADELLA D, RIBEIRO DA. The role of toll like receptors (TLRs) in oral carcinogenesis. Anticancer Res. 2017;37(10):5389-5394.

[13] GüLER-YüKSEL M, HOES JN, BULTINK IEM, et al. Glucocorticoids, Inflammation and Bone. Calcif Tissue Int. 2018;102(5):592-606.

[14] JOHNSON RW, MCGREGOR NE, BRENNAN HJ, et al. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone. Bone. 2015;2015(81):343-351.

[15] TANAKA Y, TAKEUCHI T, AMANO K, et of interleukin-6 receptor inhibitor,tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF Rheumatol. 2014;24(3): 399-404.

[16] LANGE J, SAPOZHNIKOVA A, LU C, et of IL-1beta during fracture healing. J Orthop Res. 2010;28(6):778-784.

[17] CZEKANSKA EM, RALPHS JR, ALINI M, et inflammatory and chemotactic signals to regulate bone regeneration. Eur Cell Mater. 2014;28:320-334.

[18] VOSS JO, LOEBEL C, BARA JJ, et al. Effect of short-term stimulation with interleukin-1β and differentiation medium on human mesenchymal stromal cell paracrine activity in coculture with osteoblasts. BioMed Res Int. 2015;2015:.

[19] 郭成龙,魏玉娇,何玲,等.生骨再造丸对激素性股骨头坏死大鼠骨代谢及炎症细胞因子表达的影响[J].中药药理与临床,2019,35(4):170-174.

[20] 帅波,沈霖,杨艳萍,等.古方青娥丸加味干预早期非创伤性股骨头缺血性坏死骨转换标志物、血流变及炎症相关因子的变化[J].中国组织工程研究,2016,20(46):6907-6914.

[21] SODHI CP, NEAL MD, SIGGERS R, et epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. Gastroenterology. 2012;143(3):708-718.

[22] YAMAGUCHI M, WEITZMANN ,a potent suppressor of NF-κB and Smad activation in osteoblasts. Int J Mol Med. 2011;28(4):521-525.

[23] BELLEI B, PITISCI A, IZZO E, et al. Inhibition of melanogenesis by the pyridinyl imidazole class of compounds: possible involvement of the Wnt/β-catenin signaling One. 2012;7(3):e.

[24] MENG L, SUN JY. Progression of TLR4 signal pathway in osteoblast. Chinese J Osteop Bone Mineral Res. 2013;6(3):260-265.

[25] 李文锋,侯树勋,张伟佳,等.TNF-α-NFκB 对成骨细胞分化过程中BMP-2-Smad1信号通路的影响[J].中国骨质疏松杂志,2011,17(1):1-4.

文章来源：《现代中医药》 网址: http://www.xdzyyzz.cn/qikandaodu/2021/0301/408.html